{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:54:15Z","timestamp":1792662855918,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by the degeneration of upper and lower motor neurons. Defects in axonal transport have been observed pre-symptomatically in the SOD1\n                    <jats:sup>G93A<\/jats:sup>\n                    mouse model of ALS, and have been proposed to play a role in motor neuron degeneration as well as in other pathologies of the nervous system, such as Alzheimer\u2019s disease and hereditary neuropathies. In this study, we screen a library of small-molecule kinase inhibitors towards the identification of pharmacological enhancers of the axonal retrograde transport of signalling endosomes, which might be used to normalise the rate of this process in diseased neurons. Inhibitors of p38 mitogen-activated protein kinases (p38 MAPK) were identified in this screen and were found to correct deficits in axonal retrograde transport of signalling endosomes in cultured primary SOD1\n                    <jats:sup>G93A<\/jats:sup>\n                    motor neurons. In vitro knockdown experiments revealed that the alpha isoform of p38 MAPK (p38 MAPK\u03b1) was the sole isoform responsible for SOD1\n                    <jats:sup>G93A<\/jats:sup>\n                    -induced transport deficits. Furthermore, we found that acute treatment with p38 MAPK\u03b1 inhibitors restored the physiological rate of axonal retrograde transport in vivo in early symptomatic SOD1\n                    <jats:sup>G93A<\/jats:sup>\n                    mice. Our findings demonstrate the pathogenic effect of p38 MAPK\u03b1 on axonal retrograde transport and identify a potential therapeutic strategy for ALS.\n                  <\/jats:p>","DOI":"10.1038\/s41419-018-0624-8","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T08:22:49Z","timestamp":1526977369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS"],"prefix":"10.1038","volume":"9","author":[{"given":"Katherine L.","family":"Gibbs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"Kalmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena R.","family":"Rhymes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceri H.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Greensmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4319-8745","authenticated-orcid":false,"given":"Giampietro","family":"Schiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"624_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. Jr. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"624_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nbd.2017.02.004","volume":"105","author":"KJ De Vos","year":"2017","unstructured":"De Vos, K. J. & Hafezparast, M. Neurobiology of axonal transport defects in motor neuron diseases: opportunities for translational research? Neurobiol. Dis. 105, 283\u2013299 (2017).","journal-title":"Neurobiol. Dis."},{"key":"624_CR3","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.1073\/pnas.1006869107","volume":"107","author":"LG Bilsland","year":"2010","unstructured":"Bilsland, L. G. et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl Acad. Sci. USA 107, 20523\u201320528 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"624_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1126\/science.1258138","volume":"346","author":"K Bercsenyi","year":"2014","unstructured":"Bercsenyi, K. et al. Tetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus. Science 346, 1118\u20131123 (2014).","journal-title":"Science"},{"key":"624_CR5","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/j.1600-0854.2007.00645.x","volume":"8","author":"K Deinhardt","year":"2007","unstructured":"Deinhardt, K., Reversi, A., Berninghausen, O., Hopkins, C. R. & Schiavo, G. Neurotrophins Redirect p75NTR from a clathrin-independent to a clathrin-dependent endocytic pathway coupled to axonal transport. Traffic 8, 1736\u20131749 (2007).","journal-title":"Traffic"},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.nbd.2017.02.009","volume":"105","author":"R Prior","year":"2017","unstructured":"Prior, R., Van Helleputte, L., Benoy, V. & Van Den Bosch, L. Defective axonal transport: a common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiol. Dis. 105, 300\u2013320 (2017).","journal-title":"Neurobiol. Dis."},{"key":"624_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2017.04.010","volume":"105","author":"ST Brady","year":"2017","unstructured":"Brady, S. T. & Morfini, G. A. Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases. Neurobiol. Dis. 105, 273\u2013282 (2017).","journal-title":"Neurobiol. Dis."},{"key":"624_CR8","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1073\/pnas.1200658109","volume":"109","author":"P Marinkovic","year":"2012","unstructured":"Marinkovic, P. et al. Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 109, 4296\u20134301 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"624_CR9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nrd2999","volume":"8","author":"LK Chico","year":"2009","unstructured":"Chico, L. K., Van Eldik, L. J. & Watterson, D. M. Targeting protein kinases in central nervous system disorders. Nat. Rev. Drug Discov. 8, 892\u2013909 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"624_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2012.06.003","volume":"246","author":"NM Kanaan","year":"2013","unstructured":"Kanaan, N. M. et al. Axonal degeneration in Alzheimer\u2019s disease: when signaling abnormalities meet the axonal transport system. Exp. Neurol. 246, 44\u201353 (2013).","journal-title":"Exp. Neurol."},{"key":"624_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jnen\/63.2.113","volume":"63","author":"C Bendotti","year":"2004","unstructured":"Bendotti, C. et al. Activated p38MAPK is a novel component of the intracellular inclusions found in human amyotrophic lateral sclerosis and mutant SOD1 transgenic mice. J. Neuropathol. Exp. Neurol. 63, 113\u2013119 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"624_CR12","doi-asserted-by":"publisher","first-page":"e65235","DOI":"10.1371\/journal.pone.0065235","volume":"8","author":"GA Morfini","year":"2013","unstructured":"Morfini, G. A. et al. Inhibition of fast axonal transport by pathogenic SOD1 involves activation of p38 MAP kinase. PloS ONE 8, e65235 (2013).","journal-title":"PloS ONE"},{"key":"624_CR13","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.nbd.2006.12.023","volume":"26","author":"M Dewil","year":"2007","unstructured":"Dewil, M., dela Cruz, V. F., Van Den Bosch, L. & Robberecht, W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol. Dis. 26, 332\u2013341 (2007).","journal-title":"Neurobiol. Dis."},{"key":"624_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.mcn.2005.09.009","volume":"31","author":"P Veglianese","year":"2006","unstructured":"Veglianese, P. et al. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol. Cell. Neurosci. 31, 218\u2013231 (2006).","journal-title":"Mol. Cell. Neurosci."},{"key":"624_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S1044-7431(03)00022-8","volume":"223","author":"M Tortarolo","year":"2003","unstructured":"Tortarolo, M. et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 223, 180\u2013192 (2003).","journal-title":"Mol. Cell. Neurosci."},{"key":"624_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.mcn.2004.02.009","volume":"26","author":"S Ackerley","year":"2004","unstructured":"Ackerley, S. et al. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 26, 354\u2013364 (2004).","journal-title":"Mol. Cell. Neurosci."},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fncel.2014.00140","volume":"8","author":"M Terenzio","year":"2014","unstructured":"Terenzio, M., Golding, M. & Schiavo, G. siRNA screen of ES cell-derived motor neurons identifies novel regulators of tetanus toxin and neurotrophin receptor trafficking. Front. Cell. Neurosci. 8, 140 (2014).","journal-title":"Front. Cell. Neurosci."},{"key":"624_CR18","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.15252\/embj.201387579","volume":"33","author":"M Terenzio","year":"2014","unstructured":"Terenzio, M. et al. Bicaudal-D1 regulates the intracellular sorting and signalling of neurotrophin receptors. EMBO J. 33, 1582\u20131598 (2014).","journal-title":"EMBO J."},{"key":"624_CR19","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1242\/jcs.00727","volume":"116","author":"G Lalli","year":"2003","unstructured":"Lalli, G., Gschmeissner, S. & Schiavo, G. Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons. J. Cell Sci. 116, 4639\u20134650 (2003).","journal-title":"J. Cell Sci."},{"key":"624_CR20","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1073\/pnas.81.19.6044","volume":"81","author":"M Schliwa","year":"1984","unstructured":"Schliwa, M., Ezzell, R. M. & Euteneuer, U. erythro-9-[3-(2-hydroxynonyl)]adenine is an effective inhibitor of cell motility and actin assembly. Proc. Natl Acad. Sci. USA 81, 6044\u20136048 (1984).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"624_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0026-895X(25)10036-9","volume":"48","author":"PF Mery","year":"1995","unstructured":"Mery, P. F., Pavoine, C., Pecker, F. & Fischmeister, R. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol. Pharmacol. 48, 121\u2013130 (1995).","journal-title":"Mol. Pharmacol."},{"key":"624_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature10936","volume":"484","author":"AJ Firestone","year":"2012","unstructured":"Firestone, A. J. et al. Small-molecule inhibitors of the AAA\u2009+\u2009ATPase motor cytoplasmic dynein. Nature 484, 125\u2013129 (2012).","journal-title":"Nature"},{"key":"624_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0168-0102(99)00012-7","volume":"33","author":"M Kano","year":"1999","unstructured":"Kano, M. et al. Effects of ALCAR on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats. Neurosci. Res. 33, 207\u2013213 (1999).","journal-title":"Neurosci. Res."},{"key":"624_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1083\/jcb.200501085","volume":"169","author":"D Kieran","year":"2005","unstructured":"Kieran, D. et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169, 561\u2013567 (2005).","journal-title":"J. Cell Biol."},{"key":"624_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00091-1","volume":"7","author":"RR Sama","year":"2017","unstructured":"Sama, R. R. et al. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Sci. Rep. 7, 115 (2017).","journal-title":"Sci. Rep."},{"key":"624_CR26","first-page":"805","volume":"12","author":"E Cano","year":"1996","unstructured":"Cano, E., Doza, Y. N., Ben-Levy, R., Cohen, P. & Mahadevan, L. C. Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. Oncogene 12, 805\u2013812 (1996).","journal-title":"Oncogene"},{"key":"624_CR27","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/1087057113497401","volume":"18","author":"PR Young","year":"2013","unstructured":"Young, P. R. Perspective on the discovery and scientific impact of p38 MAP kinase. J. Biomol. Screen. 18, 1156\u20131163 (2013).","journal-title":"J. Biomol. Screen."},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1523\/JNEUROSCI.22-11-04335.2002","volume":"22","author":"ET Coffey","year":"2002","unstructured":"Coffey, E. T. et al. c-Jun N-terminal protein kinase (JNK) 2\/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J. Neurosci. 22, 4335\u20134345 (2002).","journal-title":"J. Neurosci."},{"key":"624_CR29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.stemcr.2017.02.019","volume":"8","author":"A Bhinge","year":"2017","unstructured":"Bhinge, A., Namboori, S. C., Zhang, X., VanDongen, A. M. J. & Stanton, L. W. Genetic Correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in Amyotrophic Lateral Sclerosis. Stem Cell Rep. 8, 856\u2013869 (2017).","journal-title":"Stem Cell Rep."},{"key":"624_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3565(24)39230-4","volume":"293","author":"DC Underwood","year":"2000","unstructured":"Underwood, D. C. et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293, 281\u2013288 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"624_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jneumeth.2015.09.018","volume":"257","author":"KL Gibbs","year":"2016","unstructured":"Gibbs, K. L., Kalmar, B., Sleigh, J. N., Greensmith, L. & Schiavo, G. In vivo imaging of axonal transport in murine motor and sensory neurons. J. Neurosci. Methods 257, 26\u201333 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"624_CR32","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/cne.23917","volume":"524","author":"LH Comley","year":"2016","unstructured":"Comley, L. H., Nijssen, J., Frost-Nylen, J. & Hedlund, E. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology. J. Comp. Neurol. 524, 1424\u20131442 (2016).","journal-title":"J. Comp. Neurol."},{"key":"624_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/path.1700810105","volume":"81","author":"TB Teoh","year":"1961","unstructured":"Teoh, T. B. The effects of methyl cellulose in rats with special reference to splenomegaly, anaemia and the problem of hypersplenism. J. Pathol. Bacteriol. 81, 33\u201344 (1961).","journal-title":"J. Pathol. Bacteriol."},{"key":"624_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1679\/aohc1950.12.201","volume":"12","author":"Y Yanagimoto","year":"1957","unstructured":"Yanagimoto, Y., Wada, H. & Yamamura, E. The effect on the liver by intraperitoneal injection of methyl-cellulose. Arch. Hist. Jpn. 12, 201\u2013209 (1957).","journal-title":"Arch. Hist. Jpn."},{"key":"624_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.tibs.2015.08.003","volume":"40","author":"KL Gibbs","year":"2015","unstructured":"Gibbs, K. L., Greensmith, L. & Schiavo, G. Regulation of axonal transport by protein kinases. Trends Biochem. Sci. 40, 597\u2013610 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"624_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tips.2003.08.003","volume":"24","author":"C Krieger","year":"2003","unstructured":"Krieger, C., Hu, J. H. & Pelech, S. Aberrant protein kinases and phosphoproteins in amyotrophic lateral sclerosis. Trends Pharmacol. Sci. 24, 535\u2013541 (2003).","journal-title":"Trends Pharmacol. Sci."},{"key":"624_CR37","doi-asserted-by":"publisher","first-page":"15495","DOI":"10.1523\/JNEUROSCI.5599-11.2012","volume":"32","author":"DJ Mitchell","year":"2012","unstructured":"Mitchell, D. J. et al. Trk activation of the ERK1\/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport. J. Neurosci. 32, 15495\u201315510 (2012).","journal-title":"J. Neurosci."},{"key":"624_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/cm.20122","volume":"63","author":"J Motil","year":"2006","unstructured":"Motil, J. et al. Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: regulation by multiple phosphorylation events. Cell. Motil. Cytoskelet. 63, 266\u2013286 (2006).","journal-title":"Cell. Motil. Cytoskelet."},{"key":"624_CR39","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/emboj.2008.133","volume":"27","author":"E Colin","year":"2008","unstructured":"Colin, E. et al. Huntingtin phosphorylation acts as a molecular switch for anterograde\/retrograde transport in neurons. EMBO J. 27, 2124\u20132134 (2008).","journal-title":"EMBO J."},{"key":"624_CR40","doi-asserted-by":"publisher","first-page":"17207","DOI":"10.1523\/JNEUROSCI.4108-11.2011","volume":"31","author":"JP Pandey","year":"2011","unstructured":"Pandey, J. P. & Smith, D. S. A Cdk5-dependent switch regulates Lis1\/Ndel1\/dynein-driven organelle transport in adult axons. J. Neurosci. 31, 17207\u201317219 (2011).","journal-title":"J. Neurosci."},{"key":"624_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00018-002-8425-7","volume":"59","author":"CC Miller","year":"2002","unstructured":"Miller, C. C. et al. Axonal transport of neurofilaments in normal and disease states. Cell. Mol. Life. Sci. 59, 323\u2013330 (2002).","journal-title":"Cell. Mol. Life. Sci."},{"key":"624_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1471-4159.2003.01505.x","volume":"84","author":"CA Farah","year":"2003","unstructured":"Farah, C. A., Nguyen, M. D., Julien, J. P. & Leclerc, N. Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 84, 77\u201386 (2003).","journal-title":"J. Neurochem."},{"key":"624_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1471-4159.2004.02155.x","volume":"88","author":"JH Cho","year":"2004","unstructured":"Cho, J. H. & Johnson, G. V. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau\u2019s ability to bind and stabilize microtubules. J. Neurochem. 88, 349\u2013358 (2004).","journal-title":"J. Neurochem."},{"key":"624_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.12688\/f1000research.10433.1","volume":"6","author":"JN Sleigh","year":"2017","unstructured":"Sleigh, J. N., Vagnoni, A., Twelvetrees, A. E. & Schiavo, G. Methodological advances in imaging intravital axonal transport. F1000Res. 6, 200 (2017).","journal-title":"F1000Res."},{"key":"624_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6245","volume":"5","author":"VK Godena","year":"2014","unstructured":"Godena, V. K. et al. Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat. Commun. 5, 5245 (2014).","journal-title":"Nat. Commun."},{"key":"624_CR46","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","volume":"27","author":"JP Dompierre","year":"2007","unstructured":"Dompierre, J. P. et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J. Neurosci. 27, 3571\u20133583 (2007).","journal-title":"J. Neurosci."},{"key":"624_CR47","doi-asserted-by":"crossref","unstructured":"Benoy, V., et al. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. Brain (2018). PMID:29415205.","DOI":"10.1093\/brain\/awx375"},{"key":"624_CR48","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","volume":"22","author":"I Taes","year":"2013","unstructured":"Taes, I. et al. HDAC6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum. Mol. Genet. 22, 1783\u20131790 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"624_CR49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"624_CR50","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bbadis.2013.03.012","volume":"1832","author":"P McGoldrick","year":"2013","unstructured":"McGoldrick, P., Joyce, P. I., Fisher, E. M. & Greensmith, L. Rodent models of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1832, 1421\u20131436 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"624_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-016-0358-8","volume":"4","author":"M Nolan","year":"2016","unstructured":"Nolan, M., Talbot, K. & Ansorge, O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol. Commun. 4, 99 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"624_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps, S. & Julien, J. P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 14, 161\u2013176 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"624_CR53","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1021\/acschemneuro.5b00002","volume":"6","author":"SM Roy","year":"2015","unstructured":"Roy, S. M. et al. Targeting human central nervous system protein kinases: An isoform selective p38\u03b1MAPK inhibitor that attenuates disease progression in Alzheimer\u2019s disease mouse models. ACS Chem. Neurosci. 6, 666\u2013680 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"624_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6","volume":"55","author":"V Arce","year":"1999","unstructured":"Arce, V. et al. Cardiotrophin-1 requires LIFRbeta to promote survival of mouse motoneurons purified by a novel technique. J. Neurosci. Res. 55, 119\u2013126 (1999).","journal-title":"J. Neurosci. Res."},{"key":"624_CR55","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuron.2006.08.018","volume":"52","author":"K Deinhardt","year":"2006","unstructured":"Deinhardt, K. et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 52, 293\u2013305 (2006).","journal-title":"Neuron"},{"key":"624_CR56","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1242\/dmm.007237","volume":"4","author":"A Acevedo-Arozena","year":"2011","unstructured":"Acevedo-Arozena, A. et al. A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis. Dis. Model Mech. 4, 686\u2013700 (2011).","journal-title":"Dis. Model Mech."},{"key":"624_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jneumeth.2014.02.005","volume":"227","author":"JN Sleigh","year":"2014","unstructured":"Sleigh, J. N., Burgess, R. W., Gillingwater, T. H. & Cader, M. Z. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles. J. Neurosci. Methods 227, 159\u2013165 (2014).","journal-title":"J. Neurosci. Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0624-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0624-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:43:48Z","timestamp":1751636628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0624-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0624-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733281636.793575600","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"21 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"596"}}